Y-Prime
Malvern, US · 3 known investors
YPrime provides a clinical trial technology platform with patient engagement features (eConsent and eCOA) designed to accelerate trial timelines, improve data quality, and enhance participant experience for pharmaceutical companies, biotechs, and contract research organizations.
Founders & leadership
Board
MR
ET
Elizabeth TallettBoard director
RG
Richard GastineauBoard director
PB
Paul BlakeBoard director
JW
James WALKERBoard director
JP
James PuseyBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 3 rounds · 2014–2017
▶$2.1MraisedNov 2017 · 2 investors · Other TechnologyRule 506(b)
▶$2.1MraisedNov 2017 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES WALKERDirector
- MARK MAIETTAExecutive Officer
- SEAN BARKMANDirector
- MATTHEW RICEDirector
- SHAWN BLACKBURNExecutive Officer, Director
- JAIME COOKExecutive Officer
- TRAVIS MILKSDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMar 2016 · 2 investors · OtherRule 506(b)
▶$2MraisedMar 2016 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth TALLETTDirector
- Richard GASTINEAUDirector
- Jaime COOKExecutive Officer, Director
- Matthew RICEDirector
- Paul BLAKEDirector
- Shawn BLACKBURNExecutive Officer, Director
- James WALKERDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedOct 2014 · 2 investors · OtherRule 506(b)
▶$2.5MraisedOct 2014 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew RiceDirector
- Richard GastineauDirector
- Elizabeth TallettDirector
- James PuseyDirector
- Paul BlakeDirector
- Shawn BlackburnExecutive Officer, Director
- Jaime CookExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Sales commissions
- $50K
- Placement agents
- Centerstone Partners, LLC
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Y-Prime do?
- YPrime provides a clinical trial technology platform with patient engagement features (eConsent and eCOA) designed to accelerate trial timelines, improve data quality, and enhance participant experience for pharmaceutical companies, biotechs, and contract research organizations.
- Who are Y-Prime's investors?
- Y-Prime's investors include Flexpoint Ford, Gray Ventures, Ballast Point Ventures.
- How much funding has Y-Prime raised?
- Y-Prime has disclosed $6.6M raised across 3 rounds.
- Where is Y-Prime headquartered?
- Y-Prime is headquartered in Malvern, US.